| 摘要 |
<p>An antibody specifically binding to human BCMA, characterized in that the binding of said antibody is not reduced by APRIL and not reduced by BAFF, said antibody does not alter APRIL-dependent NF-ºB activation, BAFF-dependent NF-ºB activation, and does not alter NF-ºB activation without BAFF and APRIL is useful as a therapeutic agent.</p> |
